Processing, please wait...
1 演讲 / 主席 7 参会证

Roxanna SADOUGHIFAR Prof

医师
伊朗

Prof.Dr.Roxanna Sadoughifar 

Professor at University of Rome G.Marconi

Editor of  Clinical cases in Hair and Scalp Disorders by Springer Nature

Former Associate Editor of Dermatologic Therapy by Wiley

 Chief Editor of Journal of Applied Cosmetology

FUE ASIA Senior Representative In Iran

Regional Vice president of Face Aesthetic Dermatologist Society

President of the Surgical and Medical Aesthetic section of WHA

Associate Editor of journal of Cosmetic dermatology by Wiley

更多详情
add item 加入 Roxanna SADOUGHIFAR

Roxanna SADOUGHIFAR's 的日程

Roxanna SADOUGHIFAR's 的发布 (28)

Pityriasis rosea following SARS-CoV-2 vaccination: A case series.

Oct, 2021

更多详情

Journal of cosmetic dermatology

A new, innovative, and safe treatment in vitiligo: Results of a randomized, double-blinded, parallel-group study.

Jan, 2021

Vitiligo is a chronic autoimmune disease affecting around 1% of the population worldwide. No existing treatment is giving fully satisfactory results. Further investigations are welcomed for innovative and safe treatments bringing better results. This trial aimed to compare the efficacy and tolerance of various treatment protocols on vitiligo lesions. Four randomized groups of 10 patients with vitiligo covering 8% to 14% of skin surface, except hands and feet were assigned during 8 weeks to (a) UVB microphototherapy 300 to 320 nm (Bioskin-) 1 x week; (b) VITILSI- gel 2 x day; (c) VITILSI- gel 2xday + Bioskin- 1 x week; and (d) placebo 2 x day. Efficacy of the treatment was assessed by planimetry, comparing the photographs of the patients taken at baseline and after 8-week treatment. After completion of the treatment, the increase of the pigment area was 28% in G1 (Bioskin-), 19% in G2 (VITILSI-), 41% in G3 (Bioskin- + VITILSI-) and null in G4. No subject stopped the treatment and no side effect was observed. It was demonstrated that the gel under study was able per se to induce repigmentation in vitiligo lesions and that the results were significantly better when combined with NB-UVB. The protocols used in this trial resulted safe and efficient. 更多详情

Dermatologic therapy

Biorevitalization of the skin with skin boosters: Concepts, variables, and limitations.

Nov, 2020

Aging leads to diminished capacity in the functionality of all the skin layers, which in turn leads to a structurally weak and esthetically unappealing skin which is dull, dehydrated, and inelastic. Skin boosters can be defined as biological materials or bio-actives that help or encourage the skin to increase or improve its function. Boosters have been used in treating skin structural changes associated with aging as well as other factors such as corticosteroid-induced skin atrophy. Restoring the loss in skin nourishment and vital components is the concept involved in biorevitalization of the skin. The authors aim to present an update and a short review of skin boosters in this commentary. 更多详情

Journal of cosmetic dermatology
装载更多